Prepared by Dr. David Miller, FRM, Head of Quantitative Research | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-E1A010A9-20260531 | Data as of 2026-05-31
Executive Summary: netflix stock split date operates in the Healthcare industry with a market cap of $4.63B. The stock trades at 55.42x earnings and exhibits 29.2% top-line growth. Our derived fair value is $21758.7.
Rating: Outperform | Target Price: $21758.7 | Next Earnings: Jul 10
Download Full PDF Report
Price action carved a Inverse Head and Shoulders, confirmed by a 1.68x volume spike on May 26, 2026. The support at $19459 was tested.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $20343.5 would be bullish.
With a market cap of $4.63B, netflix stock split date operates in Healthcare. P/E of 55.42x is backed by 29.2% growth.
Relative to Healthcare peers, netflix stock split date sits at the 71th percentile in valuation, offering a potential value opportunity.
Beta of 1.84 suggests netflix stock split date is {beta_desc} volatile than the market, influencing hedging strategies.
Dark pool prints show a 18%% surge in block trades, indicating institutional accumulation before Jul 10 earnings.
Short float at 12.6% is below the sector average, reducing squeeze risk. Institutional ownership is 73%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $17690 | $16805.5 |
| Market Cap | $4.63B | $5.09B |
| P/E Ratio | 55.42x | 47.1x |
| EPS (TTM) | $319.2 | $287.28 |
| Dividend Yield | 3.66% | 2.6% |
| Revenue Growth | 29.2% | 17.5% |
| Target Price | $21758.7 | - |
| Beta | 1.84 | 1.00 |